RedHill Biopharma Ltd.

RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of gastrointestinal and infectious diseases management. Our three FDA-approved drugs are promoted in the U.S. by a dedicated and experienced sales team, focused on driving increasing revenues. We have also built an exciting, advanced and largely de-risked R&D pipeline of proprietary late-stage clinical development drug candidates addressing major unmet medical needs.